Purified methanolic extract of salacia reticulata wight. Ameliorates Insulin resistance and metabolic alterations in rats fed high fructose diet

International Journal of Pharmacology

Volumn 6, Issue 4, 2010, Pages 348-354

  Rafiq, Mohamed ^a   Mitra, S K ^a  

^a Himalaya Health Care   (India)

Author keywords

Acarbose; Glucose intolerance; Insulin resistance; Rosiglitazone; Salacia reticulata

Indexed keywords

ACARBOSE; GLUCOSE; INSULIN SENSITIZING AGENT; METHANOL; PLANT EXTRACT; ROSIGLITAZONE; SALACIA RETICULATA EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOHYDRATE DIET; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG TREATMENT FAILURE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HYPERINSULINEMIA; INSULIN RESISTANCE; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PLANT ROOT; RAT; SALACIA; SALACIA RETICULATA; VALIDATION STUDY;

EID: 77955603320     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2010.386.392     Document Type: Article

References (34)

1. Akase, T., T. Shimada, Y. Harasawa, T. Akase and Y. Ikeya et al., 2009. Preventive effects of Salacia reticulata on obesity and metabolic disorders in TSOD Mice. Evid Based Compl. Alternat Med., 10.1093/ecam/nep052
2. Breuer, H.W.H., 2003. Reviews of acarbose therapeutic strategies in the long-term treatment and in prevention of type-2 diabetes. Int. J. Clin. Pharm. Ther.,41: 421-440.
3. Chen, C.C., I.M. Liu and J.T. Cheng, 2006. Improvement of Insulin resistance by miracle fruit (Synsepalum dulcificum) in fructose-rich chow-fed rats. Phytother. Res., 20: 987-992.
4. Chiassen, J.L., G.J. Robert, R. Gomes, M. Hanefeld and A. Karosik et al., 2003. Acarbose treatment and rest of cardiovascular disease and hypertension in patients with impaired glucose tolerance, the STOP-NIDDM trial. JAMA, 290: 486-494.
5. Choi, S.B., B.S. Ko, S.K. Park, J.S. Jang and S. Park, 2006. Insulin sensitizing and α-glucoamylase inhibitoiy action of sennosides rheins and rhaponticin in Rhei Rhizoma. Life Sci., 78: 934-942.
6. Clissold, S.P. and C. Edwards, 1988. Acarbose: A preliminary review of its pharmacodynamic and pharmacokinetic properties and theraeutic potential. Drugs, 35: 214-243.
7. Gamble, J.S., 1997. Flora of the Presidency of Madras (reprinted). Bishen Singh Mahendra Pal Singh, Dehradun, India.
8. Harati, M., M. Ali and M. Messripour, 2003. Effect of vanadyl sulfate on fructose-induced insulin resistance rat. Iran. Biomed. J., 7: 179-182.
9. Husain, A. and O.P. Virmani, 1992. Dictionaiy of Indian Medicinal Plants. CIMAP, Lucknow, pp: 400.
10. Hwang, I.S., B. Hoffman, H. Ho and Reaven, 1983. Fructose induced insulin resistance and hypertension in rats. Hypertension, 5: 881-886.
11. Jarvis, M.F. and R.C. Kahn, 2000. Understanding the pathogenesis and treatment of insulin resistance and type 2 Diabetes mellitus: What can we learn from Transgenic and knockout mice? Diabetes Metab., 26: 433-448.
12. Keren, P., R. Hemi, D. Le Roith, A. Karasik and E. Elhananyi, 1997. A molecular basis for insulin resistance. J. Biol. Chem., 272: 29911-29918.
13. Latha, R.C.R. and P. Daisy, 2010. Influence of Terminalia bellerica Roxb. fruit extracts on biochemical parameters in streptozotocin diabetic rats. Int. J. Pharmacol., 6: 89-96.
14. Mitra, S.K., S. Gopumadhavan, T.S. Muralidhar, S.D. Anturlikar and M.B. Sujatha, 1996. Effect of herbomineral preparation D-400 in streptozotocin induced diabetic rats. J. Ethanopharmacol., 54: 41-46.
15. Mlinar, B., J. Marc, A. Janez and M. Pfeifer, 2007. Molecular mechanisms of insulin resistance and associated disesases. Clin. Chimica Acta, 375: 20-35.
16. Moller, D.E., 2001. New drug targets for type 2 diabetes and the metabolic syndrome. Nature, 414: 821-827.
17. Monika, C.Z., M. Pete, S. Kristina, C. Vojteh and F. Robert, 2006. Toxic and lethal effects of ostreolysin, a cytolytic protein fromedible oyster mushroom (Pleurotus ostreatus), in rodents. Toxicon, 48: 264-271.
18. Nadkarni, K.M., 1993. The Indian Materia Medica. 1st Edn., Popular Prakashan Pvt. Ltd., Bombay, pp: 1089.
19. Nakamura, K., S. Yamagishi, T. Matsui and H. Inoue, 2005. Acarbose an α-glucosidase inhibitor, improves insulin resistance in fructose-fed rats. Drugs Exp. Clin. Res., 31: 155-159.
20. Nandhini, A.T.A., V. Thirunavukkarasu, M.K. Ravichandran and C.V. Anuradha, 2005. Effect of taurine onbiomarkers of oxidative stress in tissues of fructose-fed insulin-resistant rats. Singapore Med. J., 46: 82-87.
21. Pari, L. and S. Ramalingam, 2006. Role of diasulin, an herbal formulation on antioxidant status in chemical induced diabetes. Int. J. Pharmacol., 2: 110-115.
22. Rafiq, M. and S.K. Mitra, 2009. α-Glucosidase inhibitory activity of purified methanolic extract of Salacia reticulata and its effect on blood glucose level in rats. Antiseptic, 106: 606-610.
23. Relph, A.D., 1999. Pharmacological therapy for Type 2 diabetes melhtus. Ann. Intern. Med., 131: 281-303.
24. Seda, O., L. Kazdova, D. Krenova and V. Kren, 2002. Rosiglitazone improves insulin resistance, lipid profile and promotes adiposity in genetic model of metabolic syndrome X. Folia. Biologica, 48: 237-241.
25. Sou, S., H. Takahashi, R. Yamasaki, H. Yuki and K. Chika et al., 2001. α-glucosidase inhibitors with a 4,5,6,7-Tetrachlorophthamide skeleton pendanted with cycloalkyl Dicarba-closo-dodecaborane group. Chem. Pharm. Bull., 49: 791-793.
26. Srinivasan, S. and B. Karundevi, 2005. Comparative evaluation of hypoglycaemic activity of two medicinal plants in alloxan diabetic rats. Int. J. Pharmacol., 1: 267-276.
27. Tiwari, A.K. and J. Madhusudana-Rao, 2002. Diabetes melhtus and multiple therapeutic approaches of phytochemicals: Present status and future prospects. Curr. Sci., 83: 30-38.
28. Wagner, H. and S. Bladt, 1995. Screening of Unknown Commercial Drugs. Springer Publications, New York, ISBN: 3-540-88676-8, pp: 349-354.
29. Wanier, P.K., V.P.K. Nambiar, C. Ramankutty and R. Vasudevan, 1996. Indian Medicinal Plants: A Compendium of 500 Species. 5th Vol., Orient Longman Ltd., Hyderabad, ISBN: 10-8125003010, pp: 47.
30. Yoshikawa, M., T. Murakami, H. Shimada and H. Matsuda, 1997. Salicinol, potent antidiabeticprinciple with unique thiosugar sulfonium sulfate structure from the ayurvedic traditional medicine Salacia reticulata in Sri Lanka and India. Tetrahedron Lett., 38: 8367-8370.
31. Yoshikawa, M., T. Murakami, K. Yashiro and H. Matsuda, 1998. Kotalanol, a potent α-glucosidase inhibitor with thiosugar sulfonium sulfate structure, from antidiabetic ayurvedic medicine Salacia reticulata. Chem. Pharm. Bull., 46: 1339-1340.
32. Yoshikawa, M., N. Nishida, H. Shimoda, M. Takada, Y. Kawahara and H. Matsuda, 2001. Polyphenol constituents from Salacia species: Quantitative analysis of mangiferin with α-glycosidase and aldose reductase inhibitoiy activities. J. Pharma. Soc. Jap., 121:371-378.
33. Yoshikawa, M., H. Shimoda, N. Nishida, M. Takada and H. Matsuda, 2002a. Salacia reticulata and its polyphenolic constituents with lipase inhibitoiy and lipolytic activities have mild antiobesity effects in rats. J. Nutr., 132: 1819-1824.
34. Yoshikawa, M., T. Morikawa, H. Matsuda, G. Tanabe and O. Muraoka, 2002b. Absolute stereostructure of potent alpha-glucosidase inhibitor, Salacinol, with unique thiosugar sulfonium sulfate inner salt structure from Salacia reticulata. Bioorg. Med. Chem., 10: 1547-1554.